The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis
Abstract
Objective: To investigate the differences in bone turnover between diabetic patients and controls. Design: A systematic review and meta-analysis. Methods: A literature search was conducted using the databases Medline at PubMed and EMBASE. The free text search terms ‘diabetes mellitus’ and ‘bone turnover’, ‘sclerostin’, ‘RANKL’, ‘osteoprotegerin’, ‘tartrate-resistant acid’ and ‘TRAP’ were used. Studies were eligible if they investigated bone turnover markers in patients with diabetes compared with controls. Data were extracted by two reviewers. Results: A total of 2881 papers were identified of which 66 studies were included. Serum levels of the bone resorption marker C-terminal cross-linked telopeptide (−0.10 ng/mL (−0.12, −0.08)) and the bone formation markers osteocalcin (−2.51 ng/mL (−3.01, −2.01)) and procollagen type 1 amino terminal propeptide (−10.80 ng/mL (−12.83, −8.77)) were all lower in patients with diabetes compared with controls. Furthermore, s-tartrate-resistant acid phosphatase was decreased in patients with type 2 diabetes (−0.31 U/L (−0.56, −0.05)) compared with controls. S-sclerostin was significantly higher in patients with type 2 diabetes (14.92 pmol/L (3.12, 26.72)) and patients with type 1 diabetes (3.24 pmol/L (1.52, 4.96)) compared with controls. Also, s-osteoprotegerin was increased among patients with diabetes compared with controls (2.67 pmol/L (0.21, 5.14)). Conclusions: Markers of both bone formation and bone resorption are decreased in patients with diabetes. This suggests that diabetes mellitus is a state of low bone turnover, which in turn may lead to more fragile bone. Altered levels of sclerostin and osteoprotegerin may be responsible for this.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Vestergaard, P. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,808
Self-citationHerzog, R., Álvarez-Pasquin, M. J., Díaz, C., Del Barrio, J. L., Estrada, J. M., & Gil, Á. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-154 · Cited by 1,652
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture
Janghorbani, M., Van Dam, R. M., Willett, W. C., & Hu, F. B. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm106 · Cited by 1,209
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Vilsbøll, T., Krarup, T., Sonne, J., Madsbad, S., Vølund, A., Juul, A. G., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021873 · Cited by 528
In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
Farr, J. N., Drake, M. T., Amin, S., Melton, L. J., McCready, L. K., & Khosla, S. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2106 · Cited by 499
Bone Loss and Bone Turnover in Diabetes
Krakauer, J. C., Mckenna, M. J., Fenn Buderer, N., Rao, D. S., Whitehouse, F. W., & Parfitt, A. M. (1995) · Diabetes · doi:10.2337/diab.44.7.775 · Cited by 498
Muscelli, E., Mari, A., Casolaro, A., Camastra, S., Seghieri, G., Gastaldelli, A., Holst, J. J., & Ferrannini, E. (2008) · Diabetes · doi:10.2337/db07-1315 · Cited by 409
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
Theodorakis, M. J., Carlson, O., Michopoulos, S., Doyle, M. E., Juhaszova, M., Petraki, K., & Egan, J. M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2004 · Cited by 396
Vollmer, K., Holst, J. J., Baller, B., Ellrichmann, M., Nauck, M. A., Schmidt, W. E., & Meier, J. J. (2008) · Diabetes · doi:10.2337/db07-1124 · Cited by 356
Leslie, W. D., Rubin, M. R., Schwartz, A. V., & Kanis, J. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1759 · Cited by 352
Osteoblast physiology in normal and pathological conditions
Neve, A., Corrado, A., & Cantatore, F. P. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1086-1 · Cited by 331
Manolagas, S. C., & Almeida, M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0259 · Cited by 330
The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
Yamada, C., Yamada, Y., Tsukiyama, K., Yamada, K., Udagawa, N., Takahashi, N., Tanaka, K., Drucker, D. J., Seino, Y., & Inagaki, N. (2008) · Endocrinology · doi:10.1210/en.2007-1292 · Cited by 318
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
García-Martín, A., Rozas-Moreno, P., Reyes-García, R., Morales-Santana, S., García-Fontana, B., García-Salcedo, J. A., & Muñoz-Torres, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2186 · Cited by 311
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Gennari, L., Merlotti, D., Valenti, R., Ceccarelli, E., Ruvio, M., Pietrini, M. G., Capodarca, C., Franci, M. B., Campagna, M. S., Calabrò, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2958 · Cited by 272
Mechanism of circadian variation in bone resorption
Bjarnason, N. H., Henriksen, E. E. G., Alexandersen, P., Christgau, S., Henriksen, D. B., & Christiansen, C. (2002) · Bone · doi:10.1016/s8756-3282(01)00662-7 · Cited by 262
Biochemical bone turnover markers in diabetes mellitus — A systematic review
Starup-Linde, J., & Vestergaard, P. (2016) · Bone · doi:10.1016/j.bone.2015.02.019 · Cited by 239
Self-citationSzulc, P., & Delmas, P. D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0660-9 · Cited by 220
Dobnig, H., Piswanger-Sölkner, J. C., Roth, M., Obermayer-Pietsch, B., Tiran, A., Strele, A., Maier, E., Maritschnegg, P., Sieberer, C., & Fahrleitner-Pammer, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0460 · Cited by 217
Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes
Furst, J. R., Bandeira, L. C., Fan, W.-W., Agarwal, S., Nishiyama, K. K., McMahon, D. J., Dworakowski, E., Jiang, H., Silverberg, S. J., & Rubin, M. R. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1437 · Cited by 213
Starup-Linde, J., Eriksen, S. A., Lykkeboe, S., Handberg, A., & Vestergaard, P. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2676-7 · Cited by 210
Self-citationThe Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 209
Bone structure and turnover in type 2 diabetes mellitus
Shu, A., Yin, M. T., Stein, E., Cremers, S., Dworakowski, E., Ives, R., & Rubin, M. R. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1595-0 · Cited by 206
Gerdhem, P., Isaksson, A., Åkesson, K., & Obrant, K. J. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1877-5 · Cited by 204
Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus
Manavalan, J. S., Cremers, S., Dempster, D. W., Zhou, H., Dworakowski, E., Kode, A., Kousteni, S., & Rubin, M. R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1546 · Cited by 195
Iepsen, E. W., Lundgren, J. R., Hartmann, B., Pedersen, O., Hansen, T., Jørgensen, N. R., Jensen, J.-E. B., Holst, J. J., Madsbad, S., & Torekov, S. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1176 · Cited by 193
Shanbhogue, V. V., Hansen, S., Frost, M., Jørgensen, N. R., Hermann, A. P., Henriksen, J. E., & Brixen, K. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2573 · Cited by 183
Gaudio, A., Privitera, F., Battaglia, K., Torrisi, V., Sidoti, M. H., Pulvirenti, I., Canzonieri, E., Tringali, G., & Fiore, C. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1901 · Cited by 183
Tanaka, K.-I., Yamaguchi, T., Kanazawa, I., & Sugimoto, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.091 · Cited by 178
Keegan, T. H. M., Schwartz, A. V., Bauer, D. C., Sellmeyer, D. E., & Kelsey, J. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1547 · Cited by 178
Li, C.-I., Liu, C.-S., Lin, W.-Y., Meng, N.-H., Chen, C.-C., Yang, S.-Y., Chen, H.-J., Lin, C.-C., & Li, T.-C. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2462 · Cited by 176
Effects of diabetes drugs on the skeleton
Meier, C., Schwartz, A. V., Egger, A., & Lecka-Czernik, B. (2016) · Bone · doi:10.1016/j.bone.2015.04.026 · Cited by 174
Ardawi, M.-S. M., Akhbar, D. H., AlShaikh, A., Ahmed, M. M., Qari, M. H., Rouzi, A. A., Ali, A. Y., Abdulrafee, A. A., & Saeda, M. Y. (2013) · Bone · doi:10.1016/j.bone.2013.06.029 · Cited by 172
High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
Wittrant, Y., Gorin, Y., Woodruff, K., Horn, D., Abboud, H. E., Mohan, S., & Abboud-Werner, S. L. (2008) · Bone · doi:10.1016/j.bone.2008.02.006 · Cited by 164
Diabetes, Collagen, and Bone Quality
Saito, M., Kida, Y., Kato, S., & Marumo, K. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0202-7 · Cited by 153
Sanz, C., Vázquez, P., Blázquez, C. P., Barrio, P. A., Álvarez, M., & Blázquez, E. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2009 · Cited by 140
Young Women With Type 1 Diabetes Have Lower Bone Mineral Density That Persists Over Time
Mastrandrea, L. D., Wactawski‐Wende, J., Donahue, R. P., Hovey, K. M. O., Clark, A., & Quattrin, T. (2008) · Diabetes Care · doi:10.2337/dc07-2426 · Cited by 135
Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?
Gregorio, F., Cristallini, S., Santeusanio, F., Filipponi, P., & Fumelli, P. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90126-0 · Cited by 134
Effects of high glucose and high insulin concentrations on osteoblast function in vitro
Cunha, J. S., Ferreira, V. M., Maquigussa, E., Naves, M. A., & Boim, M. A. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1913-x · Cited by 131
Yamamoto, M., Yamauchi, M., & Sugimoto, T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2143 · Cited by 129
Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus
Abdalrahaman, N., McComb, C., Foster, J. E., McLean, J., Lindsay, R. S., McClure, J., McMillan, M., Drummond, R. S., Gordon, D. S., McKay, G. A., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2465 · Cited by 123
Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus
Armas, L. A. G., Akhter, M. P., Drincic, A., & Recker, R. R. (2011) · Bone · doi:10.1016/j.bone.2011.09.055 · Cited by 116
Miazgowski, T., & Czekalski, S. (1998) · Osteoporosis International · doi:10.1007/s001980050082 · Cited by 115
Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus
Henríquez, M. S., Dominguez, M., Navarro, M. C., Segarra, M. C., Hernández, D., de Pablos-Velasco, P. L., & Betancor, P. (1996) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)00062-3 · Cited by 114
Osteoporosis and risk of fracture in patients with diabetes: an update
Montagnani, A., Gonnelli, S., Alessandri, M., & Nuti, R. (2011) · Aging Clinical and Experimental Research · doi:10.1007/bf03351073 · Cited by 113
Octreotide Abolishes the Acute Decrease in Bone Turnover in Response to Oral Glucose
Clowes, J. A., Allen, H. C., Prentis, D. M., Eastell, R., & Blumsohn, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021447 · Cited by 113
Berberoğlu, Z., Gürsoy, A., Bayraktar, N., Yazıcı, A. C., Tütüncü, N. B., & Demirağ, N. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0431 · Cited by 112
Bone metabolism in male patients with type 2 diabetes
Achemlal, L., Tellal, S., Rkiouak, F., Nouijai, A., Bezza, A., Derouiche, E. M., Ghafir, D., & Maghraoui, A. E. (2005) · Clinical Rheumatology · doi:10.1007/s10067-004-1070-9 · Cited by 108
Yamamoto, M., Yamaguchi, T., Nawata, K., Yamauchi, M., & Sugimoto, T. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2537 · Cited by 106
Differences in biochemical bone markers by diabetes type and the impact of glucose
Starup‐Linde, J., Lykkeboe, S., Gregersen, S., Hauge, E., Langdahl, B. L., Handberg, A., & Vestergaard, P. (2015) · Bone · doi:10.1016/j.bone.2015.11.004 · Cited by 97
Self-citationBone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes
Starup‐Linde, J., Lykkeboe, S., Gregersen, S., Hauge, E. M., Langdahl, B. L., Handberg, A., & Vestergaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3882 · Cited by 97
Self-citationGLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
Nuche-Berenguer, B., Lozano, D., Gutiérrez-Rojas, I., Moreno, P., Mariñoso, M. L., Esbrit, P., & Villanueva-Peñacarrillo, M. L. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0015 · Cited by 96
Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus
Olmos, J. M., Pérez‐Castrillón, J. L., García, M. T. S., Garrido, J. C., Amado, J. A., & González-Macı́as, J. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80157-2 · Cited by 87
Zhou, Y., Li, Y., Zhang, D., Wang, J., & Yang, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.013 · Cited by 87
Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
Reyes‐García, R., Rozas-Moreno, P., López-Gallardo, G., García‐Martin, A., Varsavsky, M., Avilés-Pérez, M. D., & Muñoz‐Torres, M. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0347-0 · Cited by 86
Neumann, T. E., Sämann, A., Lodes, S., Kästner, B., Franke, S., Kiehntopf, M., Hemmelmann, C., Lehmann, T., Müller, U., Hein, G. E., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03286.x · Cited by 84
Tsentidis, C., Gourgiotis, D., Kossiva, L., Doulgeraki, A. E., Marmarinos, A., Galli‐Τsinopoulou, A., & Karavanaki, K. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3422-5 · Cited by 83
Danielson, K. K., Elliott, M. E., LeCaire, T. J., Binkley, N., & Palta, M. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0763-3 · Cited by 80
Jiajue, R., Jiang, Y., Wang, O., Li, M., Xing, X., Cui, L., Yin, J., Xu, L., & Xia, W. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2714-5 · Cited by 80
van Lierop, A. H., Hamdy, N. A. T., van der Meer, R. W., Jonker, J. T., Lamb, H. J., Rijzewijk, L. J., Diamant, M., Romijn, J. A., Smit, J. W. A., & Papapoulos, S. E. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1061 · Cited by 80
Loureiro, M. B., Ururahy, M. A. G., Freire‐Neto, F. P., Oliveira, G. H. M., Duarte, V. M. G., Luchessi, A. D., Brandão‐Neto, J., Hirata, R. D. C., Hirata, M. H., Maciel-Neto, J. J., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.018 · Cited by 74
Movahed, A., Larijani, B. A., Nabipour, I., Kalantarhormozi, M., Asadipooya, K., Vahdat, K., Akbarzadeh, S., Farrokhnia, M., Assadi, M., Amirinejad, R., et al. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0367-z · Cited by 73
Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus
Lappin, D. F., Eapen, B., Robertson, D. P., Young, J., & Hodge, P. J. (2009) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01440.x · Cited by 71
Sarkar, P. D., & Choudhury, A. B. (2013) · PubMed · Cited by 70
Petrova, N. L., Dew, T. K., Musto, R., Sherwood, R. A., Bates, M., Moniz, C. F., & Edmonds, M. E. (2014) · Diabetic Medicine · doi:10.1111/dme.12590 · Cited by 69
Chen, H., Li, X., Yue, R., Ren, X., Xiude, Z., & An-ming, N. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.007 · Cited by 68
Bone density and markers of bone remodeling in type 1 male diabetic patients
Alexopoulou, O., Jamart, J., Devogelaer, J., Brichard, S. M., Nayer, P. D., & Buysschaert, M. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70303-8 · Cited by 67
Kanazawa, I., Yamaguchi, T., & Sugimoto, T. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1310-6 · Cited by 66
Heilmeier, U., Carpenter, D. R., Patsch, J., Harnish, R. J., Joseph, G. B., Burghardt, A. J., Baum, T. H., Schwartz, A. V., Lang, T., & Link, T. M. (2015) · Osteoporosis International · doi:10.1007/s00198-014-2988-7 · Cited by 66
Lumachi, F., Camozzi, V., Tombolan, V., & Luisetto, G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04955.x · Cited by 66
Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.
Oz, S. G., Guven, G. S., Kılıçarslan, A., Çalık, N., Beyazıt, Y., & Sözen, T. (2006) · PubMed Central · Cited by 65
Karagüzel, G., Akçurin, S., Özdem, S., Boz, A., & Bircan, İ. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.6.805 · Cited by 58
Neumann, T. E., Hofbauer, L. C., Rauner, M., Lodes, S., Kästner, B., Franke, S., Kiehntopf, M., Lehmann, T., Müller, U. A., Wolf, G., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12364 · Cited by 57
Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus
Catalano, A., Pintaudi, B., Morabito, N., Vieste, G. D., Giunta, L., Bruno, M. L., Cucinotta, D., Lasco, A., & Benedetto, A. D. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0106 · Cited by 52
Inoue, D., Muraoka, R., Okazaki, R., Nishizawà, Y., & Sugimoto, T. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0071-9 · Cited by 41
Reduced attenuation of bone resorption after oral glucose in type 2 diabetes
Chailurkit, L., Chanprasertyothin, S., Rajatanavin, R., & Ongphiphadhanakul, B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03159.x · Cited by 39
EMAS Group, Laurent, M. R., Cook, M. J., Gielen, E., Ward, K. A., Antonio, L., Adams, J. E., Decallonne, B., Bártfai, G., Casanueva, F. F., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3656-x · Cited by 36
Tsentidis, C., Gourgiotis, D., Kossiva, L., Marmarinos, A., Doulgeraki, A. E., & Karavanaki, K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12288 · Cited by 35
Okuno, S., Ishimura, E., Tsuboniwa, N., Norimine, K., Yamakawa, K., Yamakawa, T., Shoji, S., Mori, K., Nishizawà, Y., & Inaba, M. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2003-0 · Cited by 32
Liu, Z., Jiang, H., Dong, K., Liu, S., Zhou, W., Zhang, J., Meng, L., Rausch‐Fan, X., & Xu, X. W. (2015) · Implant Dentistry · doi:10.1097/id.0000000000000196 · Cited by 31
Bhattoa, H. P., Onyeka, U., Kalina, E., Balogh, Á. L., Paragh, G., Antal‐Szalmás, P., & Káplár, M. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2254-y · Cited by 26
Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus
Singh, D. K., Winocour, P. H., Summerhayes, B., Viljoen, A., Sivakumar, G. S., & Farrington, K. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0146-z · Cited by 24
Nickolas, T. L., & Jamal, S. A. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9314-3 · Cited by 21
Lambrinoudaki, I. V., Tsouvalas, E., Vakaki, M., Kaparos, G., Stamatelopoulos, K., Augoulea, A., Pliatsika, P., Alexandrou, A. P., Creatsa, M. G., & Karavanaki, K. (2013) · International Journal of Endocrinology · doi:10.1155/2013/102120 · Cited by 16
Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
Moreno, P. R., García, R. R., García‐Martin, A., Varsavsky, M., Garcia-Salcedo, J. A., & Muñoz‐Torres, M. (2013) · PubMed · doi:10.3275/8285 · Cited by 15
Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus
Chrysis, D., Efthymiadou, A., Mermigka, A., Kritikou, D., & Spiliotis, B. E. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12384 · Cited by 15
Feldbrin, Z., & Shargorodsky, M. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2668 · Cited by 14
Bone turnover markers in statin users: A population-based analysis from the Camargo Cohort Study
Hernández, J. L., Olmos, J. M., Romaña, G., Martínez, J., Castillo, J., Yezerska, I., Ramos, C., & González-Macías, J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.02.003 · Cited by 13
Bone turnover biomarkers in obese postmenopausal Saudi women with type-ІІ diabetes mellitus
ALSelami, N. M., Noureldeen, A., Al-Ghamdi, M. A., Khan, J. A., & Moselhy, S. S. (2015) · African Health Sciences · doi:10.4314/ahs.v15i1.12 · Cited by 12
Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus
Razi, F., Esmaili, M., Nasli‐Esfahani, E., et al. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000524 · Cited by 10
An update on diabetes related skeletal fragility
Abdalrahman, N., Chen, S. C., Wang, J. R., & Ahmed, S. F. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.984687 · Cited by 4
Cited by
Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Zhou, A. Y., Panagioti, M., Esmail, A., Agius, R., Van Tongeren, M., & Bower, P. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13761 · Cited by 292
Mantovani, A., Sani, E., Fassio, A., Colecchia, A., Viapiana, O., Gatti, D., Idolazzi, L., Rossini, M., Salvagno, G., Lippi, G., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.10.001 · Cited by 68
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
Metadata
- Authors
- Hygum, K., Starup-Linde, J., Harsløf, T., Vestergaard, P., & Langdahl, B. L.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03
- Volume
- 176
- Issue
- 3
- Pages
- R137-R157
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2566941284
- Cited by
- 320
- References
- 94
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.